Catalyst Wire Dossier Catalyst Wire Dossier

Timolol 0.5%

timolol
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Timolol 0.5%, covering 2014-03-13 to 2018-09-04. Get the full timeline:

Most recent: Clinical Trial Update: BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing